Page last updated: 2024-11-04

sulfasalazine and Arthritis, Juvenile Chronic

sulfasalazine has been researched along with Arthritis, Juvenile Chronic in 60 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine."7.70Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis. ( Can, C; Dinc, A; Erdem, H; Pay, S; Simsek, I, 2000)
"AP is an important complaint in young adults with JIA and is associated with fatigue, female gender, methotrexate and sulfasalazine use."4.12Abdominal pain in Finnish young adults with juvenile idiopathic arthritis. ( Aalto, K; Glerup, M; Kautiainen, H; Peltoniemi, S; Rebane, K; Tuomi, AK, 2022)
"We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine."3.70Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis. ( Can, C; Dinc, A; Erdem, H; Pay, S; Simsek, I, 2000)
" Patients were treated with a dosage of 50 mg/kg/day of SSZ (maximum 2,000 mg/day) or placebo."2.69Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. ( Dijkmans, BA; Dijkstra, PF; Fiselier, TJ; Franssen, MJ; Kuis, W; Oostveen, JC; ten Cate, R; van Ede, CF; van Luijk, WH; van Rossum, MA; van Soesbergen, RM; van Suijlekom-Smit, LW; Wulffraat, NM; Zwinderman, AH, 1998)
"Its application for juvenile chronic arthritis (JCA) is limited so far and controversial results for the efficacy of this therapy have been published."2.69Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis. ( Dyankov, ED; Varbanova, BB, 1999)
"Sulfasalazine was stopped in 7 patients: for toxicity in 4 and for inefficacy in 3."2.67Sulfasalazine treatment in juvenile chronic arthritis: an open study. ( Goemaere, S; Joos, R; Mielants, H; van Werveke, S; Veys, EM, 1991)
"Juvenile idiopathic arthritis is the most frequent chronic rheumatic disease in childhood."2.53The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis. ( Horneff, G; Hügle, B, 2016)
"Before the biologic era, treatment of juvenile idiopathic arthritis (JIA) was often highly unsatisfactory, with children forced to endure the ill effects of lifelong disease, including pain and stiffness, disability, and even increased risk of mortality."2.49Treatment of juvenile idiopathic arthritis in the biologic age. ( Cron, RQ; Stoll, ML, 2013)
"We report on an 11-year-old girl with juvenile idiopathic arthritis, who developed Crohn's disease (CD) while taking etanercept for her arthritis."2.46Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature. ( Dick, A; Girschick, HJ; Morbach, H; Wiegering, V, 2010)
"Sulfasalazine (SSZ) has regulatory approval for treatment of inflammatory bowel disease in children and adults, and for use as a slow acting agent in adult rheumatoid arthritis (RA)."2.41Sulfasalazine for the management of juvenile rheumatoid arthritis. ( Brooks, CD, 2001)
"Prognostic factors in juvenile rheumatoid arthritis (JRA) include polyarticular onset, polyarticular disease course, and rheumatoid factor positivity; in the systemic onset subtype, persistence of systemic features at 6 months after onset confers a worse prognosis."2.41Current treatment of juvenile rheumatoid arthritis. ( Ilowite, NT, 2002)
"New information on the treatment of juvenile rheumatoid arthritis emphasizes more aggressive control of arthritis, particularly the use of methotrexate, both in low- and higher-dose regimens."2.38Treatment of juvenile rheumatoid arthritis. ( Emery, HM, 1993)
"We report a 15-year-old boy with juvenile rheumatoid arthritis who developed DIHS due to sulfasalazine, associated with reactivation of HHV-6."1.35Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation. ( Balci, DD; Dogramaci, CA; Duran, N; Peker, E, 2009)
"Sulfasalazine (SSZ) has recently been shown to be effective for the management of juvenile rheumatoid arthritis (JRA)."1.31Sulfasalazine therapy for juvenile rheumatoid arthritis. ( Chen, CC; Chiang, BL; Lin, YT; Yang, YH, 2002)
"Four children with chronic arthritis (3 juvenile rheumatoid arthritis and 1 juvenile ankylosing spondylitis) and poorly controlled chronic uveitis, were given sulphasalazine (SASP) therapy for a mean period of 3."1.30Sulphasalazine therapy in chronic uveitis of children with chronic arthritis. ( Hsieh, KH; Huang, JL; Hung, IJ, 1997)
"A 12-year-old girl with juvenile rheumatoid arthritis developed fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia, which was confirmed by liver histology and bone marrow examination, 2 weeks after initiation of sulphasalazine therapy."1.30Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin. ( Chen, LC; Hsieh, KH; Hsueh, C; Huang, JL; Hung, IJ; Lee, WY, 1998)
"Two 19 year old patients with juvenile chronic arthritis developed liver toxicity during treatment with sulphasalazine."1.28Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis. ( Caspi, D; Fuchs, D; Yaron, M, 1992)
"In 38 children with juvenile chronic arthritis the authors tested Sulphasalazine in an open clinical trial."1.28[Sulfasalazine in the treatment of chronic juvenile arthritis]. ( Havelka, S; Hoza, J; Kadlecová, T; Nĕmcová, D, 1989)

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-19908 (13.33)18.7374
1990's20 (33.33)18.2507
2000's15 (25.00)29.6817
2010's11 (18.33)24.3611
2020's6 (10.00)2.80

Authors

AuthorsStudies
Rebane, K1
Tuomi, AK1
Kautiainen, H1
Peltoniemi, S1
Glerup, M1
Aalto, K3
Broekaert, IJ3
Klein, A3
Windschall, D3
Rogalski, B3
Weller-Heinemann, F3
Oommen, P3
Küster, M3
Foeldvari, I3
Minden, K3
Hospach, A3
Hufnagel, M3
Berger, T3
Geikowski, T3
Quietzsch, J3
Horneff, G4
Macaraeg, M1
Schulert, GS1
Sukharomana, M1
Charuvanij, S1
Tarkiainen, M2
Tynjälä, P2
Vähäsalo, P2
Kröger, L2
Lahdenne, P2
Ayaz, NA1
Karadağ, ŞG1
Koç, R1
Demirkan, FG1
Çakmak, F1
Sönmez, HE1
Marino, A1
De Souza, M1
Giani, T1
Cimaz, R1
Hissink Muller, P1
Brinkman, DMC1
Schonenberg-Meinema, D1
van den Bosch, WB1
Koopman-Keemink, Y2
Brederije, ICJ1
Bekkering, PW1
Kuijpers, TW2
Van Rossum, M1
van Suijlekom-Smit, LWA1
van den Berg, JM2
Boehringer, S1
Allaart, CF2
Ten Cate, R7
Stoll, ML1
Cron, RQ2
Lorenzo, N1
Cantera, D1
Barberá, A1
Alonso, A1
Chall, E1
Franco, L1
Ancizar, J1
Nuñez, Y1
Altruda, F1
Silengo, L1
Padrón, G1
Del Carmen Dominguez, M1
Agarwal, NN1
Patil, D1
Nagendra, S1
Jadhav, SM1
Hügle, B1
Hissink Muller, PC1
Brinkman, DM1
Schonenberg, D1
Brederije, IC1
Bekkering, WP1
van Rossum, MA6
van Suijlekom-Smit, LW6
Wiegering, V1
Morbach, H1
Dick, A1
Girschick, HJ1
Balci, DD1
Peker, E1
Duran, N1
Dogramaci, CA1
Piñana, E1
Lei, SH1
Merino, R1
Melgosa, M1
De La Vega, R1
Gonzales-Obeso, E1
Ramírez, E1
Borobia, A1
Carcas, A1
Malin, M1
Putto-Laurila, A1
Honkanen, V1
Váncsa, A1
Tóth, B1
Szekanecz, Z1
Burgos-Vargas, R1
Vázquez-Mellado, J1
Pacheco-Tena, C1
Hernández-Garduño, A1
Goycochea-Robles, MV1
Zwinderman, AH4
Boers, M3
Dijkmans, BA5
van Soesbergen, RM5
Fiselier, TJ5
Franssen, MJ5
Wulffraat, NM5
Kuis, W5
van Luijk, WH5
Oostveen, JC5
Dijkstra, PF2
SAIRANEN, E1
LAAKSONEN, AL1
Wieringa, H1
Bouayed, K1
Brik, H1
Zakari, A1
Mikou, N1
Dehbi, F1
Scherer, HU1
Burmester, GR1
Takeyama, J1
Umebayashi, H1
Inagaki, T1
Beukelman, T1
Guevara, JP1
Albert, DA1
Sherry, DD2
Burnham, JM1
Kümmerle-Deschner, J1
Dannecker, G1
Emery, HM1
Gedalia, A1
Barash, J1
Press, J1
Buskila, D1
McCarthy, C1
Coughlan, R1
Haagsma, CJ1
van Riel, PL1
Huang, JL3
Hung, IJ2
Hsieh, KH2
Gunnarsson, I1
Kanerud, L1
Pettersson, E1
Lundberg, I1
Lindblad, S1
Ringertz, B1
van Ede, CF1
Chen, LC2
Lee, WY1
Hsueh, C1
Harada, S1
Mitsunobu, F1
Kodama, F1
Hosaki, Y1
Mifune, T1
Tsugeno, H1
Okamoto, M1
Yamamura, M1
Makino, H1
Tanizaki, Y1
Sharma, S1
Lian, T1
Brittenden, J1
Pearson, S1
Emery, P1
Varbanova, BB1
Dyankov, ED1
Pepmueller, PH1
Moore, TL1
Pay, S1
Dinc, A1
Simsek, I1
Can, C1
Erdem, H1
Brooks, CD1
Ilowite, NT1
Chen, CC1
Lin, YT1
Yang, YH1
Chiang, BL1
Smith, MS1
Barker, JD1
Caspi, D1
Fuchs, D1
Yaron, M1
Rooney, M1
Suschke, HJ1
Joos, R1
Veys, EM1
Mielants, H1
van Werveke, S1
Goemaere, S1
Settas, L1
Alexiou, P1
Dimitriadis, G1
Mata-Tsi, E1
Souliou, E1
Papapanagiotou, J1
Tourkantonis, A1
Hoza, J2
Kadlecová, T2
Nĕmcová, D2
Havelka, S2
Rosenberg, AM1
Duffy, CM1
Laxer, RM1
Silverman, ED1
Ozdogan, H1
Turunç, M1
Deringöl, B1
Yurdakul, S1
Yazici, H1
Bliddal, H1
Helin, P1
Dülgeroğlu, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Anti-TNF Therapy Plus Methotrexate, Combination Therapy of DMARDs, and Methotrexate Alone in Very Early Polyarticular Juvenile Idiopathic Arthritis. A National Randomized Multicenter Clinical Trial.[NCT01015547]Phase 360 participants (Actual)Interventional2003-05-31Completed
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients (Pharmachild) Treated With Biologic Agents and/or Methotrexate. A PRINTO/PRES Registry[NCT01399281]9,000 participants (Anticipated)Observational2011-12-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

13 reviews available for sulfasalazine and Arthritis, Juvenile Chronic

ArticleYear
Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
    Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:17

    Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Clinical Trials as Topic; Humans; Methotrex

2020
Treatment of juvenile idiopathic arthritis in the biologic age.
    Rheumatic diseases clinics of North America, 2013, Volume: 39, Issue:4

    Topics: Abatacept; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Mo

2013
The role of synthetic drugs in the biologic era: therapeutic strategies for treating juvenile idiopathic arthritis.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:5

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Drug Therapy, Combination; Humans; H

2016
Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature.
    Rheumatology international, 2010, Volume: 30, Issue:6

    Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Art

2010
[Biologicals in the treatment of rheumatic diseases].
    Deutsche medizinische Wochenschrift (1946), 2006, Oct-13, Volume: 131, Issue:41

    Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monocl

2006
Treatment of juvenile rheumatoid arthritis.
    Current opinion in rheumatology, 1993, Volume: 5, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Erythropoietin; gamma-Globulins

1993
Combination of second-line antirheumatic drugs.
    Annals of medicine, 1997, Volume: 29, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cyclosporine; Drug Therapy, Combinat

1997
Juvenile spondyloarthropathies.
    Current opinion in rheumatology, 2000, Volume: 12, Issue:4

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Reactive; Child; Female; Germany;

2000
Sulfasalazine for the management of juvenile rheumatoid arthritis.
    The Journal of rheumatology, 2001, Volume: 28, Issue:4

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Humans; Sulfasalazine; Treatment Outcome

2001
Current treatment of juvenile rheumatoid arthritis.
    Pediatrics, 2002, Volume: 109, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arth

2002
Is there a disease-modifying drug for juvenile chronic arthritis?
    British journal of rheumatology, 1992, Volume: 31, Issue:9

    Topics: Administration, Oral; Antimalarials; Arthritis, Juvenile; Child; Forecasting; Gold; Humans; Immuniza

1992
Advanced drug therapy for juvenile rheumatoid arthritis.
    The Journal of pediatrics, 1989, Volume: 114, Issue:2

    Topics: Adrenal Cortex Hormones; Antimalarials; Arthritis, Juvenile; Child; Gold; Humans; Immunosuppressive

1989
Drug therapy for juvenile arthritis.
    Comprehensive therapy, 1989, Volume: 15, Issue:10

    Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antimet

1989

Trials

14 trials available for sulfasalazine and Arthritis, Juvenile Chronic

ArticleYear
Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial.
    Pediatric rheumatology online journal, 2019, Dec-16, Volume: 17, Issue:1

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Drug Therapy, Combination; Female; Hum

2019
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial.
    Annals of the rheumatic diseases, 2019, Volume: 78, Issue:1

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Blood Sedimentation; Child; Child, Preschool;

2019
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.
    Pediatric rheumatology online journal, 2017, Feb-06, Volume: 15, Issue:1

    Topics: Administration, Oral; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Drug Admin

2017
Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Annals of the rheumatic diseases, 2011, Volume: 70, Issue:9

    Topics: Adolescent; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Prescho

2011
A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
    Annals of the rheumatic diseases, 2002, Volume: 61, Issue:10

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Doub

2002
Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method.
    Arthritis and rheumatism, 2003, Volume: 48, Issue:2

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Arthrography; Child; Child, Preschool; Female

2003
Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score.
    Arthritis and rheumatism, 2005, Volume: 52, Issue:9

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthrography; Child; Disease Progression; Female; Humans;

2005
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment.
    Annals of the rheumatic diseases, 2007, Volume: 66, Issue:11

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Drug Administration

2007
Sulphasalazine in the treatment of pauciarticular-onset juvenile chronic arthritis.
    Clinical rheumatology, 1993, Volume: 12, Issue:4

    Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Male; Severity of Illness

1993
Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group.
    Arthritis and rheumatism, 1998, Volume: 41, Issue:5

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Arthrography; Child; Child, Preschool; Diseas

1998
Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
    Advances in experimental medicine and biology, 1999, Volume: 455

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Infa

1999
Sulfasalazine treatment in juvenile chronic arthritis: an open study.
    The Journal of rheumatology, 1991, Volume: 18, Issue:6

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Child, Preschool; C

1991
Sulphasalazine and Delagil--a comparative study in patients with juvenile chronic arthritis.
    Acta Universitatis Carolinae. Medica, 1991, Volume: 37, Issue:1-2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Chloroquine; Female; Humans; Ma

1991
Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.
    The Journal of rheumatology, 1986, Volume: 13, Issue:1

    Topics: Adolescent; Arthritis, Juvenile; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female;

1986

Other Studies

33 other studies available for sulfasalazine and Arthritis, Juvenile Chronic

ArticleYear
Abdominal pain in Finnish young adults with juvenile idiopathic arthritis.
    Scandinavian journal of gastroenterology, 2022, Volume: 57, Issue:10

    Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheuma

2022
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Development of Inflammatory Bowel Disease in Children With Juvenile Idiopathic Arthritis Treated With Biologics.
    Journal of pediatric gastroenterology and nutrition, 2023, 02-01, Volume: 76, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Colitis, Ulcerative; Crohn Di

2023
Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
    RMD open, 2023, Volume: 9, Issue:1

    Topics: Adult; Arthritis, Juvenile; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Lymphohisti

2023
Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.
    Clinical rheumatology, 2023, Volume: 42, Issue:6

    Topics: Arthritis, Juvenile; Child; Humans; Injections, Intra-Articular; Retrospective Studies; Sulfasalazin

2023
Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study.
    Rheumatology international, 2020, Volume: 40, Issue:7

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumati

2020
APL-2, an altered peptide ligand derived from heat-shock protein 60, induces interleukin-10 in peripheral blood mononuclear cell derived from juvenile idiopathic arthritis patients and downregulates the inflammatory response in collagen-induced arthritis
    Clinical and experimental medicine, 2015, Volume: 15, Issue:1

    Topics: Adolescent; Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Juvenile; Autoantigen

2015
Bilateral hip pain in a young man? It may be worth considering juvenile-onset ankylosing spondylitis (JAS).
    BMJ case reports, 2015, Oct-28, Volume: 2015

    Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Hip Joint; Humans; Male; Methylprednisolo

2015
Sulfasalazine-induced hypersensitivity syndrome in a 15-year-old boy associated with human herpesvirus-6 reactivation.
    Cutaneous and ocular toxicology, 2009, Volume: 28, Issue:1

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Drug Eruptions; Herpesvirus 6, Human; Humans;

2009
DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Drug Eruptions; Drug Therapy, C

2010
BTK gene mutation in two non-identical twins with X-linked agammaglobulinemia associated with polyarticular juvenile idiopathic arthritis.
    The Israel Medical Association journal : IMAJ, 2011, Volume: 13, Issue:9

    Topics: Adult; Agammaglobulinaemia Tyrosine Kinase; Agammaglobulinemia; Anti-Inflammatory Agents, Non-Steroi

2011
THE RESULTS OF GOLD THERAPY IN JUVENILE RHEUMATOID ARTHRITIS.
    Annales paediatriae Fenniae, 1964, Volume: 10

    Topics: Adolescent; Arthritis; Arthritis, Juvenile; Biomedical Research; Child; Chloroquine; Drug Therapy; G

1964
[Hemophagocytic syndrome occurring in polyarticular juvenile arthritis treated by salazopyrine].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2006, Volume: 13, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Drug Combinations; Glucosamine;

2006
Renal involvement in a patient with juvenile idiopathic arthritis presenting after treatment for Hodgkin lymphoma.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:5

    Topics: Arthritis, Juvenile; Child; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Hematu

2007
Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada.
    The Journal of rheumatology, 2007, Volume: 34, Issue:9

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Canada; Child

2007
Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
    Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:8

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Child, Preschool; Desensitization, Immunologic; Dose-Resp

1995
Sulphasalazine desensitisation in patients with arthritis.
    Irish journal of medical science, 1994, Volume: 163, Issue:5

    Topics: Adult; Aged; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Desensitization, Immu

1994
Sulphasalazine therapy in chronic uveitis of children with chronic arthritis.
    Asian Pacific journal of allergy and immunology, 1997, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Chronic Disease; Female; Humans

1997
Predisposing factors in sulphasalazine-induced systemic lupus erythematosus.
    British journal of rheumatology, 1997, Volume: 36, Issue:10

    Topics: Adolescent; Adult; Aged; Antibodies, Antinuclear; Arthritis, Juvenile; Arthritis, Psoriatic; Arthrit

1997
Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.
    Clinical rheumatology, 1998, Volume: 17, Issue:4

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Female; Follow-Up Studies; Hepatic Encephalopathy;

1998
Sulphasalazine in the treatment of children with chronic arthritis.
    Clinical rheumatology, 1998, Volume: 17, Issue:5

    Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Clinical Trials as T

1998
Giant cell arteritis associated with rheumatoid arthritis monitored by magnetic resonance angiography.
    Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:8

    Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Female; Giant Cell Arteritis;

1999
Current treatment by United States and Canadian pediatric rheumatologists.
    The Journal of rheumatology, 1999, Volume: 26, Issue:9

    Topics: Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; C

1999
Recurrent lung shadowing in adult juvenile idiopathic arthritis.
    Annals of the rheumatic diseases, 1999, Volume: 58, Issue:12

    Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Female; Humans; Pulmonary Eosinophilia; Radiograph

1999
Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis.
    Rheumatology international, 2000, Volume: 20, Issue:1

    Topics: Adult; Antirheumatic Agents; Arthritis, Juvenile; Chloroquine; Humans; Immunoblastic Lymphadenopathy

2000
Effects of sulfasalazine treatment on serum immunoglobulin levels in children with juvenile chronic arthritis.
    Scandinavian journal of rheumatology, 2001, Volume: 30, Issue:1

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Controlled Clinical Trials as To

2001
Sulfasalazine therapy for juvenile rheumatoid arthritis.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2002, Volume: 101, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Juvenile; Azat

2002
Granulomatous ileocolitis preceded by three years of pauciarticular arthritis.
    The American journal of gastroenterology, 1978, Volume: 69, Issue:3 Pt 1

    Topics: Arthritis, Juvenile; Aspirin; Child; Crohn Disease; Granuloma; Humans; Male; Prednisone; Sulfasalazi

1978
Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:2

    Topics: Adolescent; Adult; Alkaline Phosphatase; Arthritis, Juvenile; Chemical and Drug Induced Liver Injury

1992
[Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1992, Volume: 140, Issue:9

    Topics: Adolescent; Arthritis, Juvenile; Arthritis, Reactive; Child; Dose-Response Relationship, Drug; Drug

1992
Effect of sulphasalazine in patients with juvenile chronic arthritis (JCA).
    Acta Universitatis Carolinae. Medica, 1991, Volume: 37, Issue:1-2

    Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Female; Humans; Male; Sulfasalazine

1991
[Sulfasalazine in the treatment of chronic juvenile arthritis].
    Ceskoslovenska pediatrie, 1989, Volume: 44, Issue:10

    Topics: Adolescent; Arthritis, Juvenile; Child; Child, Preschool; HLA-B27 Antigen; Humans; Sulfasalazine

1989
Leucopenia in adult Still's disease during treatment with azathioprine and sulphasalazine.
    Clinical rheumatology, 1987, Volume: 6, Issue:2

    Topics: Adult; Arthritis, Juvenile; Aspirin; Azathioprine; Drug Therapy, Combination; Humans; Leukopenia; Ma

1987
Sulfasalazine in juvenile rheumatoid arthritis.
    The Journal of rheumatology, 1988, Volume: 15, Issue:5

    Topics: Arthritis, Juvenile; Humans; Sulfasalazine

1988